Physician profile
Alexandra Arambula
NPI 1861984585
$7,912.89
in general payments reported to CMS, 2019-2025
7 companies · $3,444 in 2025
The $3,444 reported for 2025 was more than what 83% of Otology & Neurotology providers received nationally (typical 2025 total: $411).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,790 · 2022: $1,013 · 2023: $1,665 · 2025: $3,444.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,457 · Food and Beverage: $1,653.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,457.00 |
| Food and Beverage | $1,652.56 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,207.97 | 2021-2023 | N/A, Na, Core |
| Med-El Corporation | $3,043.64 | 2025 | Mi1250 Synchrony 2 Flexsoft, Adhear Professional Kit, Bci 602 Kit |
| Medtronic, INC. | $1,197.41 | 2021-2022 | |
| Iotamotion, INC. | $232.38 | 2025 | Iotasoft |
| Aroa Biosurgery Incorporated | $141.36 | 2025 | |
| Phadia US INC. | $63.36 | 2023 | Immunocap |
| Cochlear Americas | $26.77 | 2025 | Baha, Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alexandra Arambula listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.